These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24056910)

  • 1. Combining small molecules for cell reprogramming through an interatomic analysis.
    Feltes BC; Bonatto D
    Mol Biosyst; 2013 Nov; 9(11):2741-63. PubMed ID: 24056910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming.
    Jung DW; Kim WH; Williams DR
    ACS Chem Biol; 2014 Jan; 9(1):80-95. PubMed ID: 24245936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical strategies for stem cell biology and regenerative medicine.
    Zhu S; Wei W; Ding S
    Annu Rev Biomed Eng; 2011 Aug; 13():73-90. PubMed ID: 21513460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.
    Desponts C; Ding S
    Methods Mol Biol; 2010; 636():207-18. PubMed ID: 20336525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of epigenome-modifying small molecules in induced pluripotent stem cells.
    Lu J; Kong X; Luo C; Li KK
    Med Res Rev; 2013 Jul; 33(4):790-822. PubMed ID: 22581616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
    Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
    Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the efficiency of direct reprogramming of human mesenchymal stem cells into mature neuronal-like cells with the combination of small molecule modulators of chromatin modifying enzymes, SMAD signaling and cyclic adenosine monophosphate levels.
    Alexanian AR; Liu QS; Zhang Z
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1633-8. PubMed ID: 23665234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovering small molecules to control stem cell fate.
    Andrews PD
    Future Med Chem; 2011 Sep; 3(12):1539-49. PubMed ID: 21882946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise review: The magic act of generating induced pluripotent stem cells: many rabbits in the hat.
    Mostoslavsky G
    Stem Cells; 2012 Jan; 30(1):28-32. PubMed ID: 21948613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic stem cell extracts: use in differentiation and reprogramming.
    Han J; Sidhu K
    Regen Med; 2011 Mar; 6(2):215-27. PubMed ID: 21391855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.
    Li W; Ding S
    Trends Pharmacol Sci; 2010 Jan; 31(1):36-45. PubMed ID: 19896224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurosteroid dehydroepiandrosterone could improve somatic cell reprogramming.
    Shoae-Hassani A; Sharif S; Verdi J
    Cell Biol Int; 2011 Oct; 35(10):1037-41. PubMed ID: 21355850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemically induced pluripotent stem cells (CiPSCs): a transgene-free approach.
    Masuda S; Wu J; Hishida T; Pandian GN; Sugiyama H; Izpisua Belmonte JC
    J Mol Cell Biol; 2013 Oct; 5(5):354-5. PubMed ID: 24014886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
    Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
    Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring bovine fetal fibroblast reprogramming utilizing a bovine NANOG promoter-driven EGFP reporter system.
    Lei L; Li L; Du F; Chen CH; Wang H; Keefer CL
    Mol Reprod Dev; 2013 Mar; 80(3):193-203. PubMed ID: 23280629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.